Niaid preclinical development support
Ended Awarded Last action
- Contract number
- HHSN27200007
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,044,103
Award facts
- Opportunity
-
- NIHAI2015035 Solicitation number
- Contract value 100% obligated
- $2,044,103.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Funding Only Action | $27,042 | |
| Funding Only Action | $13,763 | |
| Other Administrative Action | $0 | |
| Change Order | $803,174 | |
| Original award | $1,200,124 |
About this award
This is a prime contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL) on September 20, 2017. The contract has a potential value of $2,044,103.00 and is a Delivery Order for NIAID Preclinical Development Support services. The contract has a completion date of December 31, 2022 and is not set-aside.
ABL is a contract research and manufacturing organization that specializes in gene therapies, vaccines, oncolytics, and immunotherapies. They have been awarded over $35 million in federal contracts to support product development for agencies including NIH and HHS. Under this contract, ABL will provide biologics manufacturing, testing, storage, shipping, and quality assurance services to support NIAID's preclinical development programs. The contract may be associated with larger IDIQ vehicles that ABL holds to provide these services across NIH and HHS.
Quick answers
Who was awarded contract HHSN27200007?
HHSN27200007 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 20, 2017.
How much is contract HHSN27200007 worth?
The government has obligated $2,044,103 on HHSN27200007.
Is contract HHSN27200007 an order under another contract?
Yes. HHSN27200007 is a delivery order under HHSN272201700010I, an indefinite delivery contract.
Was contract HHSN27200007 competed?
The extent of competition for HHSN27200007 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award